Clinical reviews have shown that combining GLP-1 therapies with other weight-loss medications like phentermine and topiramate can lead to more significant reductions in body weight and waist circumference compared to using one medication alone
While gallstones can happen to anyone, there are some factors that increase the risk of developing them: Being female, especially when there is extra estrogen in the body due to pregnancy, hormone replacement therapy, or birth control Being of Latin American or Indigenous American descent Having a family history of gallstones Having certain conditions, such as diabetes or Crohns disease Being overweight or obese Other gallbladder problems It is possible to experience other gallbladder problems, including: Acalculous gallbladder disease : A form of gallbladder inflammation that occurs without gallstones, most often as an acute and potentially life-threatening condition, particularly in critically ill individuals
Older adults may experience dizziness or dehydration more noticeably due to lower baseline fluid intake or existing medications
These issues are typically linked to indirect effects such as gastrointestinal symptoms, altered eating patterns, or nocturnal hypoglycaemia rather than a direct pharmacological action
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around your individual GLP-1 receptor sensitivity by analyzing key variants in the GLP1R gene (rs6923761)
Published 2016 Jul 26
